iShares U.S. Pharmaceuticals ETF (IHE)

BATS BZX Real-Time Price
As of 11:52am ET
 +1.20 / +0.62%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.

No recent news for iShares U.S. Pharmaceuticals ETF.


1 month+2.29% 3 years+11.03%
3 months+6.79% 5 years+6.66%
1 year+5.16% Since inception+10.30%
Data through 05/25/2022

Quote Details

Previous close$192.92
Open day’s range194.12 – 194.39
Net asset value (NAV)192.44 (05/24/2022)
Daily volume2,286
Average volume (3 months)9,972
Data as of 11:52am ET, 05/26/2022

Peer Comparisonvs. Health ETFs

Performance 5-yr return+6.66%+11.31%
Expense Gross exp ratio0.42%1.00%
Risk 5 year sharpe ratio0.360.52
Net assets$394.5M$1.9B
Average market cap$75.0B$41.8B
Average P/E18.125.8
Dividend / Share--0.27%


IEHS iShares Evolved U.S. Healthcare Staples ...
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson23.69%
PFE Pfizer20.36%
MRK Merck5.07%
LLY Eli Lilly and Co4.94%
RPRX Royalty Pharma PLC4.93%
BMY Bristol-Myers Squibb4.91%
VTRS Viatris Inc4.24%
ZTS Zoetis Inc4.16%
CTLT Catalent Inc4.08%
ELAN Elanco Animal Health Inc4.07%